Over the Period of Three Years, More Than 10,000 Persons Passed Examination in PET-Center in Ufa
The PET-Center in Ufa started reception of patients in March 2014 and became the first center commissioned by RUSNANO’s portfolio company PET-Technology. For three years of operation more than 10,000 persons passed PET/CT-diagnostics of oncological diseases. As of June 2017, more than 41,000 persons were checked up in the federal network.
According to the statistics, the number of oncology patients in Russia is increasing by half a million persons every year. The technology of PET/CT-scanning (positron emission tomography coupled with computerized tomography) allows to detect cancer at early stages, when the patient has a chance of complete recovery.
PET-Center of PET-Technology in Ufa is located in the territory of one of the largest specialized oncologic dispensaries in Russia, which for the period of its existence has provided assistance to many thousands of patients suffering from virtually any types oncological diseases.
“A great work has been done during three years from the moment of opening of the center in Ufa. The residents of the Republic of Bashkortostan and the Volga Federal District gained access to high-tech medical aid in the form of diagnostics and treatment of oncological diseases. The center rendered assistance to tens of thousands persons. These are not just dry figures for us—these are saved lives. This is not only our merit; we would not achieve that result without support of local doctors and regional authorities. We hope that we will keep the pace in future”, noted the managing director for the investment activity of the Management Company RUSNANO, Olga Shpichko.
“It took PET-Technology just a few years to create the network of nuclear medicine centers and become the leader in the sphere of diagnostics opportunities of nuclear medicine. The Ufa center was the first center, which started reception of patients in 2014. We are grateful to the administration of the Republic of Bashkortostan for its all-round support in organization, creation and operation of the center of nuclear medicine in Ufa. Only through joint efforts we can change the lives of tens of thousands of oncologic patient that need modern diagnostic techniques”, said the General Director of PET-Technology, Diana Kobesova.
In-house production of radiopharmaceuticals used in diagnostics, quality control laboratory, modern PET/CT-scanner and the high level of training of specialists guarantee precision and accuracy of the examination.
“We successfully diagnose tumors that can hardly be diagnosed by other diagnostic techniques. The majority of our patients have neoplasms in lungs, brain, mamma, prostata gland and lymphomas”, says radiotherapist, radiologist of the Ufa center, Guzel Muslyumova.
Patients can pass diagnostics in the PET-center in Ufa under the Program of State Guarantees of Free Medical Aid to Citizens, voluntary medical insurance programs or at their own expense.
Currently, the federal network of PET-Technology includes eight PET-Centers located in Moscow, Ufa, Ekaterinburg, Lipetsk, Belgorod, Tambov, Kursk and Orel. As of June 2017, more than 41,000 persons were checked up in the federal network.
RUSNANO Joint-Stock Company was founded in March 2011 through reorganization of state corporation Russian Corporation of Nanotechnologies. JSC RUSNANO contributes to implementation of the state policy on the development of the nanotechnology industry by investing directly and through investment funds of nanotechnology in financially effective high-technology projects providing the development of new production facilities in the Russian Federation. Its primary investment focus is in electronics, optoelectronics and telecommunications, healthcare and biotechnology, metallurgy and metalwork, energy, mechanical engineering and instrument making, construction and industrial materials, chemicals and petrochemicals. 100 percent of RUSNANO’s shares are state owned. Thanks to RUSNANO’s investments, there are currently 95 factories and R&D Centers opened in 37 regions in Russia.
Management of assets of RUSNANO JSC is carried out by Limited Liability Company established in December 2013, RUSNANO Management Company. Anatoly Chubais is the Chairman of its Executive Board.
Work to establish nanotechnology infrastructure and carry out educational programs is fulfilled by RUSNANO’s Fund for Infrastructure and Educational Programs, which was also established during the reorganization of the Russian Corporation of Nanotechnologies.
* * *
PET-Technology LLC, RUSNANO’s Portfolio Company, was founded in 2011 in order to implement the project “Establishment of a network of regional PET/CT Centers for diagnostic procedures”—Nuclear Medicine Centers.
Currently, there are 10 diagnostic centres in operation in Moscow, Kursk, Belgorod, Yekaterinburg, Ufa, Lipetsk, Orel, Tambov, Togliatti and Samara, as well as 2
The company’s overall goal is to increase the availability of highly effective methods of diagnosis and treatment of cancer in Russia. In accordance with the territorial strategy for the development of nuclear medicine centres, PET-Technology plans to open 10 new diagnostic centres by 2020, and 25 by 2025.